Registered number
13713302
DS Pharma UK Limited
Filleted Accounts
31 October 2025

DS Pharma UK Limited
Registered number: | 13713302
Balance Sheet
as at 31 October 2025
|  |  |  | 2025 |  |  | 2024
£ | £
Called up share capital not paid |  |  |  | - |  |  | -
Fixed assets |  |  |  | - |  |  | -
Current assets |  |  | 37,206 |  |  | 2,675
Prepayments and accrued income |  |  | - |  |  | -
|  |  | 37,206 |  |  | 2,675
Creditors: amounts falling due within one year |  |  | (62,185) |  |  | (36,905)
Net current liabilities |  |  |  | (24,979) |  |  | (34,230)
Total assets less current liabilities |  |  |  | (24,979) |  |  | (34,230)
Creditors: amounts falling due after more than one year |  |  |  | - |  |  | -
Provisions for liabilities |  |  |  | - |  |  | -
Accruals and deferred income |  |  |  | - |  |  | -
Net liabilities |  |  |  | (24,979) |  |  | (34,230)
Capital and reserves |  |  |  | (24,979) |  |  | (34,230)
Number | Number
Average number of employees |  |  |  | 1 |  |  | 1
[Loans to directors, guarantees made by the company on behalf of directors]
[Capital commitments, pension commitments, other financial commitments and contingent liabilities]
The company is a private company limited by shares and incorporated in England. Its registered office is .
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared in accordance with the micro entity provisions of the Companies Act 2006 and FRS 105, The Financial Reporting Standard applicable to the Micro-entities Regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
FADL,Muna Abdullahi
Director
Approved by the board on 4 November 2025

DS Pharma UK Limited 13713302 false 2024-11-01 2025-10-31 2025-10-31 VT Final Accounts July 2024 FADL,Muna Abdullahi No description of principal activity 13713302 2023-11-01 2024-10-31 13713302 core:WithinOneYear 2024-10-31 13713302 core:AfterOneYear 2024-10-31 13713302 2024-11-01 2025-10-31 13713302 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 13713302 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 13713302 countries:England 2024-11-01 2025-10-31 13713302 bus:Director40 2024-11-01 2025-10-31 13713302 bus:Micro-entities 2024-11-01 2025-10-31 13713302 bus:FilletedAccounts 2024-11-01 2025-10-31 13713302 2025-10-31 13713302 core:WithinOneYear 2025-10-31 13713302 core:AfterOneYear 2025-10-31 13713302 2024-10-31 iso4217:GBP xbrli:pure